Увійти

Готові списки джерел за темами / E06X / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: E06X.

Статті в журналах з теми "E06X"

Автор: Grafiati

Опубліковано: 11 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "E06X".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Biswas, Tapan K., Paul A. VanderLaan, Xuchu Que, Ayelet Gonen, Paulette Krishack, Christoph J. Binder, Joseph L. Witztum, Godfrey S. Getz, and Catherine A. Reardon. "CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr−/− Mice." Antibodies 9, no. 3 (July 3, 2020): 30. http://dx.doi.org/10.3390/antib9030030.

Повний текст джерела

Анотація:

Natural antibodies (NAbs) are important regulators of tissue homeostasis and inflammation and are thought to have diverse protective roles in a variety of pathological states. E06 is a T15 idiotype IgM NAb exclusively produced by B-1 cells, which recognizes the phosphocholine (PC) head group in oxidized phospholipids on the surface of apoptotic cells and in oxidized LDL (OxLDL), and the PC present on the cell wall of Streptococcus pneumoniae. Here we report that titers of the E06 NAb are selectively increased several-fold in Cd1d-deficient mice, whereas total IgM and IgM antibodies recognizing other oxidation specific epitopes such as in malondialdehyde-modified LDL (MDA-LDL) and OxLDL were not increased. The high titers of E06 in Cd1d-deficient mice are not due to a global increase in IgM-secreting B-1 cells, but they are specifically due to an expansion of E06-secreting splenic B-1 cells. Thus, CD1d-mediated regulation appeared to be suppressive in nature and specific for E06 IgM-secreting cells. The CD1d-mediated regulation of the E06 NAb generation is a novel mechanism that regulates the production of this specific oxidation epitope recognizing NAb.

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Palmieri, Michela, Teenamol E. Joseph, Aaron Warren, Horacio Gomez-acevedo, Jinhu Xiong, Joseph Lee Witztum, Stavros C. Manolagas, and Elena Ambrogini. "Blocking Oxidized Phospholipids Attenuates the Age-Associated, but Not the Ovariectomy- or Unloading- Induced, Bone Loss in Mice." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A231—A232. http://dx.doi.org/10.1210/jendso/bvab048.470.

Повний текст джерела

Анотація:

Abstract Oxidized phospholipids (OxPL), such as oxidized phosphatidylcholine, are generated by oxidative stress (OS)-induced lipid peroxidation. E06 IgM is a natural antibody that recognizes the phosphocholine (PC) moiety of OxPLs, but not native PLs. Generation of transgenic mice expressing a single chain (scFv) form of its antigen-binding domain, “E06-scFv” mice, protects against atherosclerosis, hepatic steatosis and high fat diet-induced loss of bone mass. In addition, E06-scFv increases cancellous and cortical bone mass in both male and female adult mice fed chow diet, by increasing bone formation. Age-related bone loss is associated with increased OS and lipid peroxidation, and is characterized by a reduction in osteoblast number and bone formation. Oxidative stress is involved also in the bone loss caused by sex-steroid deficiency and elevated OS markers are found in unloading-induced bone loss, raising the possibility that an increase of OxPLs induced by OS might be contributing to the pathogenesis of these conditions as well. We aged homozygous E06-scFv transgenic female and male mice and their wild-type littermates up to 22 and 24 months respectively. Serial DXA BMD every 3 months showed that overexpression of E06-scFv attenuated the age-associated bone loss in both sexes. In addition, male and female E06-scFv transgenic mice also accumulated less fat mass than WT littermates during aging. Micro-CT analysis revealed that E06-scFv attenuated the age-associated decline in cancellous, but not cortical, bone mass. The histological analysis of the vertebrae indicated that the aged E06-scFv transgenic mice had increased osteoblasts and decreased osteoclasts compared to the WT mice. To investigate whether the beneficial effect of the E06-scFv could be seen after ovariectomy, 4.5 month old E06-scFv homozygous females and WT controls were ovariectomized (OVX). DXA and micro-CT measurements 6 weeks post- surgery indicated that, unlike aging, E06-scFv did not protect against OVX-induced bone loss in either the cancellous or the cortical compartment. Lastly, we tail-suspended 5.5 month old male mice and sacrificed them 21 days later. E06-scFv transgenic mice had similar cortical bone loss compared to WT mice. In conclusion, the E06-scFV transgene attenuates the age-associated cancellous bone loss in both female and male mice, but has no effect on the OVX- or unloading-induced bone loss. These results fully support our hypothesis that an increase in PC-OxPLs with age, caused at least in part by a decrease in natural anti-PC antibodies, contributes to the age-associated bone loss. This evidence provides proof of concept that blocking PC-OxPLs represents a therapeutic approach to countering the increase of PC-OxPLs with age and their adverse effects on age-related bone loss as well as atherosclerosis and NASH. It also confirms that the mechanisms of cancellous and cortical bone loss are distinct.

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Yeang, Calvin, Devin Hasanally, Xuchu Que, Ming-Yow Hung, Aleksandra Stamenkovic, David Chan, Rakesh Chaudhary, et al. "Reduction of myocardial ischaemia–reperfusion injury by inactivating oxidized phospholipids." Cardiovascular Research 115, no. 1 (May 30, 2018): 179–89. http://dx.doi.org/10.1093/cvr/cvy136.

Повний текст джерела

Анотація:

Abstract Aims Myocardial ischaemia followed by reperfusion (IR) causes an oxidative burst resulting in cellular dysfunction. Little is known about the impact of oxidative stress on cardiomyocyte lipids and their role in cardiac cell death. Our goal was to identify oxidized phosphatidylcholine-containing phospholipids (OxPL) generated during IR, and to determine their impact on cell viability and myocardial infarct size. Methods and results OxPL were quantitated in isolated rat cardiomyocytes using mass spectrophotometry following 24 h of IR. Cardiomyocyte cell death was quantitated following exogenously added OxPL and in the absence or presence of E06, a ‘natural’ murine monoclonal antibody that binds to the PC headgroup of OxPL. The impact of OxPL on mitochondria in cardiomyocytes was also determined using cell fractionation and Bnip expression. Transgenic Ldlr−/− mice, overexpressing a single-chain variable fragment of E06 (Ldlr−/−-E06-scFv-Tg) were used to assess the effect of inactivating endogenously generated OxPL in vivo on myocardial infarct size. Following IR in vitro, isolated rat cardiomyocytes showed a significant increase in the specific OxPLs PONPC, POVPC, PAzPC, and PGPC (P < 0.05 to P < 0.001 for all). Exogenously added OxPLs resulted in significant death of rat cardiomyocytes, an effect inhibited by E06 (percent cell death with added POVPC was 22.6 ± 4.14% and with PONPC was 25.3 ± 3.4% compared to 8.0 ± 1.6% and 6.4 ± 1.0%, respectively, with the addition of E06, P < 0.05 for both). IR increased mitochondrial content of OxPL in rat cardiomyocytes and also increased expression of Bcl-2 death protein 3 (Bnip3), which was inhibited in presence of E06. Notably cardiomyocytes with Bnip3 knock-down were protected against cytotoxic effects of OxPL. In mice exposed to myocardial IR in vivo, compared to Ldlr−/− mice, Ldlr−/−-E06-scFv-Tg mice had significantly smaller myocardial infarct size normalized to area at risk (72.4 ± 21.9% vs. 47.7 ± 17.6%, P = 0.023). Conclusions OxPL are generated within cardiomyocytes during IR and have detrimental effects on cardiomyocyte viability. Inactivation of OxPL in vivo results in a reduction of infarct size.

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Ambrogini, Elena, Michela Palmieri, Teenamol E. Joseph, Horacio Gomez-Acevedo, Gwen V. Childs, Angela K. Odle, Tiffany Miles, and Stavros C. Manolagas. "RF04 | PSUN313 A Natural Antibody Against Oxidized Phospholipids Improves Glucose Metabolism in Aging Mice." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A420. http://dx.doi.org/10.1210/jendso/bvac150.874.

Повний текст джерела

Анотація:

Abstract Oxidative stress-induced lipid peroxidation generates oxidized phospholipids (OxPL), such as oxidized phosphatidylcholine, that are pro-inflammatory moieties present on oxidized low density lipoproteins and apoptotic cells. OxPL have been implicated in the pathogenesis of cardiovascular, neurological, autoimmune, liver, and lung diseases. It has been shown earlier that OxPL decrease bone formation. Natural antibodies (NAb) produced by B-1 lymphocytes, bind OxPL and prevent their inflammatory activity. The NAb E06 blocks oxidized phosphatidylcholine, and transgenic expression of a single chain (scFv) form of the antigen-binding domain of E06 IgM (E06-scFv) prevents many age-associated diseases, such as atherosclerosis, non-alcoholic steatohepatitis and age-related bone loss. OxPL are also implicated in the pathogenesis of the metabolic syndrome and diabetes by either causing insulin resistance, increasing macrophage infiltration and inflammation in white adipose tissue, decreasing insulin gene expression, and/or causing death of pancreatic beta cells through induction of oxidative stress and amyloid protein misfolding. Consistent with this evidence, NAb produced by B-1b lymphocytes are protective against obesity associated inflammation, glucose intolerance, and insulin resistance. In the work reported here, we have investigated the impact of oxidized phosphatidylcholine on glucose metabolism and age–related glucose intolerance. To this end, we aged chow-fed female and male C57BL/6 E06-scFv transgenic mice (and their WT littermates) up to 22 and 24 months. Both male and female E06-scFv transgenic mice accumulated less fat mass than WT littermates during aging, as determined by sequential body composition measurements by DXA. Intraperitoneal glucose tolerance test, performed at 10 and at 15 months of age, showed that glucose tolerance was greater in both male and female E06-ScFv transgenic mice than WT littermates and did not differ from the glucose tolerance of young mice. Insulin sensitivity, measured by insulin tolerance test, was increased in 4- and 10-month-old old transgenic females and in 15-month-old transgenic males. There was no difference in food consumption calculated over 5 days or the production of glucose after pyruvate infusion, indicating similar liver gluconeogenesis in both strains. Physical activity or energy expenditure, measured by indirect calorimetry in 11-month-old females, was indistinguishable between transgenic and WT mice. However, E06-scFv transgenic mice exhibited a significant increase in the respiratory exchange ratio, indicating that utilization of glucose was the main metabolic source under basal conditions. Collectively, these results show that blocking oxidized phosphatidylcholine improves age–related glucose intolerance in mice fed a normal diet; hence, OxPL are major culprits of the aging-associated glucose intolerance. Therefore, targeting OxPL with a neutralizing antibody represents a novel therapeutic intervention that may simultaneously ameliorate several age-associated diseases, including the metabolic syndrome and diabetes. Presentation: Saturday, June 11, 2022 1:42 p.m. - 1:47 p.m., Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Markey, A. L., I. A. Bruce, J. Brough, R. T. Ramsden, and K. M. J. Green. "E060 Cochlear implantation in adolescents: factors influencing compliance." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 71–72. http://dx.doi.org/10.1016/s0165-5876(11)70368-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

SHEN, Li, Qian LUO, Zhi-Ping SHEN, Ling-Yu LI, Xiao-Jun ZHANG, Zhong-Qi WEI, Yi FU, Yong-Chun SONG, and Ren-Xiang TAN. "A new cytochalasin from endophytic Phomopsis sp. IFB-E060." Chinese Journal of Natural Medicines 12, no. 7 (July 2014): 512–16. http://dx.doi.org/10.1016/s1875-5364(14)60080-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Battmer, R. D., N. Cochard, A. Huarte, S. Razza, and T. Tichy. "E067 Basic CI care standards in Europe and beyond." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 73. http://dx.doi.org/10.1016/s0165-5876(11)70375-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Fujii, Yuto, Teppei SAITOH, and Yoji KURODA. "1A1-E06 Optimal Path Generation using GPS." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2010 (2010): _1A1—E06_1—_1A1—E06_4. http://dx.doi.org/10.1299/jsmermd.2010._1a1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Wedin, Rikard. "E06-04: Surgical treatment of bone metastases." Journal of Thoracic Oncology 2, no. 8 (August 2007): S233—S234. http://dx.doi.org/10.1097/01.jto.0000283010.01618.3c.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Offersen, Birgitte Vrou, and John Yarnold. "E06. Regional control matters in breast cancer." European Journal of Cancer 50 (March 2014): S12—S13. http://dx.doi.org/10.1016/s0959-8049(14)70058-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Zou, Jin, Gang Wang, Heng Li, Xiaohua Yu, and Chaoke Tang. "IgM natural antibody T15/E06 in atherosclerosis." Clinica Chimica Acta 504 (May 2020): 15–22. http://dx.doi.org/10.1016/j.cca.2020.01.024.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Philippon, B., Th Marsollier, Y. Khandazhapova, and A. Davydov. "E062 Remote fitting assistance with Neurelec Digisonic SP cochlear implant." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 72. http://dx.doi.org/10.1016/s0165-5876(11)70370-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Radulescu, L., S. Cozma, C. Niemczyk, N. Guevara, I. Gahide, E. Truy, R. Meller, et al. "E061 Multicenter evaluation of Neurelec Digisonic® SP cochlear implants reliability." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 72. http://dx.doi.org/10.1016/s0165-5876(11)70369-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Mohammadi, Milad, Beatrice Oehler, Jan Kloka, Corinna Martin, Alexander Brack, Robert Blum, and Heike L. Rittner. "Antinociception by the anti‐oxidized phospholipid antibody E06." British Journal of Pharmacology 175, no. 14 (June 7, 2018): 2940–55. http://dx.doi.org/10.1111/bph.14340.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Roodman, David G. "E06-01: Pathogenesis of lung cancer bone metastasis." Journal of Thoracic Oncology 2, no. 8 (August 2007): S231. http://dx.doi.org/10.1097/01.jto.0000283007.16865.fd.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Otten, A. J. C., L. Ketelaar, C. Rieffe, and J. H. M. Frijns. "E065 Joint attention and intention understanding in young children with a CI." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 72–73. http://dx.doi.org/10.1016/s0165-5876(11)70373-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

YASUDA, Toshihiko, Shigeyuki MIYAUCHI, Naoya SUEHIRO, and Katsuyuki TANAKA. "2P1-E06 A Trial of Omnidirectional Vehicle for Rehabilitation." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2008 (2008): _2P1—E06_1—_2P1—E06_4. http://dx.doi.org/10.1299/jsmermd.2008._2p1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Ettinger, David S. "E06-03: Management of bone metastasis - role of bisphosphonates." Journal of Thoracic Oncology 2, no. 8 (August 2007): S233. http://dx.doi.org/10.1097/01.jto.0000283009.24488.9b.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Bontempi Jr., Bruno. "O ‘Grupo de Laerte’ e a escrita da história da educação (1962-1972)." Revista Brasileira de História da Educação 19 (2019): 1–19. http://dx.doi.org/10.4025/rbhe.v19.2019.e060.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Sangenis, Luiz Fernando Conde, and Peter Johann Mainka. "Presença franciscana e supremacia jesuítica no campo da História e da História da Educação na época colonial – um diagnóstico na pesquisa historiográfica a partir da análise dos CBHE da SBHE." Revista Brasileira de História da Educação 19 (2019): 1–24. http://dx.doi.org/10.4025/rbhe.v19.2019.e061.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Santos, Ademir Valdir dos, and Ariclê Vechia. "As escolas que construímos: a história de instituições escolares na Revista Brasileira de História da Educação." Revista Brasileira de História da Educação 19 (2019): 1–26. http://dx.doi.org/10.4025/rbhe.v19.2019.e062.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Souza, Rosa Fátima de. "A contribuição dos estudos sobre grupos escolares para a historiografia da educação brasileira: reflexões para debate." Revista Brasileira de História da Educação 19 (2019): 1–24. http://dx.doi.org/10.4025/rbhe.v19.2019.e063.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Bencostta, Marcus Levy. "A escrita da arquitetura escolar na historiografia da educação brasileira (1999-2018)." Revista Brasileira de História da Educação 19 (2019): 1–26. http://dx.doi.org/10.4025/rbhe.v19.2019.e064.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Paulilo, André Luiz. "A cultura material da escola: apontamentos a partir da história da educação." Revista Brasileira de História da Educação 19 (2019): 1–24. http://dx.doi.org/10.4025/rbhe.v19.2019.e065.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Cândido, Renata Marcílio. "Festejar aqui e lá: a escrita comparada das festas escolares no Brasil e em Portugal (1890-1920)." Revista Brasileira de História da Educação 19 (2019): 1–21. http://dx.doi.org/10.4025/rbhe.v19.2019.e066.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Peres, Eliane Teresinha. "A constituição de um arquivo e a escrita da história da educação: do gesto artesão à prática científica." Revista Brasileira de História da Educação 19 (2019): 1–23. http://dx.doi.org/10.4025/rbhe.v19.2019.e067.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Xavier, Cristiane Fernanda. "História e historiografia da Educação de Jovens e Adultos no Brasil - inteligibilidades, apagamentos, necessidades, possibilidades." Revista Brasileira de História da Educação 19 (2019): 1–24. http://dx.doi.org/10.4025/rbhe.v19.2019.e068.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Albuquerque, Maria Betânia Barbosa, and Jane Elisa Otomar Buecke. "Educação não escolar: balanço da produção presente nos Congressos Brasileiros de História da Educação." Revista Brasileira de História da Educação 19 (2019): 1–22. http://dx.doi.org/10.4025/rbhe.v19.2019.e069.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

DOROFEEVA. "E060 Vasorelaxant effect of (+) and (-) enantiomers of cicletanine in isolated human mesenteric arteries." American Journal of Hypertension 11, no. 4 (April 1998): 110A. http://dx.doi.org/10.1016/s0895-7061(97)91122-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

SMITH, D. "E061 Once daily telmisartan as compared to enalapril in the treatment of hypertension." American Journal of Hypertension 11, no. 4 (April 1998): 111A. http://dx.doi.org/10.1016/s0895-7061(97)91123-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

NEUTEL, J. "E062 Dose response and pharmacokinetics of telmisartan, a new angiostensin II receptor blocker." American Journal of Hypertension 11, no. 4 (April 1998): 111A. http://dx.doi.org/10.1016/s0895-7061(97)91124-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Dou, Huijuan, Andriana Kotini, Wenli Liu, Trevor Fidler, Kaori Endo-Umeda, Xiaoli Sun, Malgorzata Olszewska, et al. "Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency." Circulation 144, no. 24 (December 14, 2021): 1940–54. http://dx.doi.org/10.1161/circulationaha.121.056414.

Повний текст джерела

Анотація:

Background: LNK/SH2B3 inhibits Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling by hematopoietic cytokine receptors. Genome-wide association studies have shown association of a common single nucleotide polymorphism in LNK (R262W, T allele) with neutrophilia, thrombocytosis, and coronary artery disease. We have shown that LNK(TT ) reduces LNK function and that LNK-deficient mice display prominent platelet–neutrophil aggregates, accelerated atherosclerosis, and thrombosis. Platelet–neutrophil interactions can promote neutrophil extracellular trap (NET) formation. The goals of this study were to assess the role of NETs in atherosclerosis and thrombosis in mice with hematopoietic Lnk deficiency. Methods: We bred mice with combined deficiency of Lnk and the NETosis-essential enzyme PAD4 (peptidyl arginine deiminase 4) and transplanted their bone marrow into Ldlr –/– mice. We evaluated the role of LNK in atherothrombosis in humans and mice bearing a gain of function variant in JAK2 (JAK2 V617F ). Results: Lnk -deficient mice displayed accelerated carotid artery thrombosis with prominent NETosis that was completely reversed by PAD4 deficiency. Thrombin-activated Lnk –/– platelets promoted increased NETosis when incubated with Lnk –/– neutrophils compared with wild-type platelets or wild-type neutrophils. This involved increased surface exposure and release of oxidized phospholipids (OxPL) from Lnk –/– platelets, as well as increased priming and response of Lnk –/– neutrophils to OxPL. To counteract the effects of OxPL, we introduced a transgene expressing the single-chain variable fragment of E06 (E06-scFv). E06-scFv reversed accelerated NETosis, atherosclerosis, and thrombosis in Lnk –/– mice. We also showed increased NETosis when human induced pluripotent stem cell–derived LNK(TT ) neutrophils were incubated with LNK(TT ) platelet/megakaryocytes, but not in isogenic LNK(CC ) controls, confirming human relevance. Using data from the UK Biobank, we found that individuals with the JAK2 VF mutation only showed increased risk of coronary artery disease when also carrying the LNK R262W allele. Mice with hematopoietic Lnk +/– and Jak2 VF clonal hematopoiesis showed accelerated arterial thrombosis but not atherosclerosis compared with Jak2 VF Lnk +/+ controls. Conclusions: Hematopoietic Lnk deficiency promotes NETosis and arterial thrombosis in an OxPL-dependent fashion. LNK(R262W) reduces LNK function in human platelets and neutrophils, promoting NETosis, and increases coronary artery disease risk in humans carrying Jak2 VF mutations. Therapies targeting OxPL may be beneficial for coronary artery disease in genetically defined human populations.

Стилі APA, Harvard, Vancouver, ISO та ін.

33

OGAWA, Yu, Amir A. F. Nassiraei, Kazuo ISHII, and Atusi KANDA. "1P1-E06 Risk Assessment and Protective Measure of Service Robots." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2009 (2009): _1P1—E06_1—_1P1—E06_4. http://dx.doi.org/10.1299/jsmermd.2009._1p1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

NISHIJIMA, Norifumi, Naoya FUJII, and Kazuo ISHII. "2A2-E06 Development of sampling device for gathering benthic organisms." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2015 (2015): _2A2—E06_1—_2A2—E06_3. http://dx.doi.org/10.1299/jsmermd.2015._2a2-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Doré, J. "E06 The commensal intestinal microbiota in health and immune diseases." Journal of Crohn's and Colitis Supplements 4, no. 1 (April 2010): 5. http://dx.doi.org/10.1016/s1873-9954(10)70010-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

TACHI, Susumu, Riichiro TADAKUMA, Naoki KAWAKAMI, Hiroyuki KAJIMOTO, and Dairoku SEKIGUCHI. "1A1-E06 Development of Master-Slave Arm for "TELESAR 2"." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2006 (2006): _1A1—E06_1—_1A1—E06_2. http://dx.doi.org/10.1299/jsmermd.2006._1a1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

SANO, Akihito, Shinya ASAI, Masahiko KAMO, Naoyuki TAKESUE, Hiromi MOCHIYAMA, and Hideo FUJIMOTO. "1A2-E06 Dynamics of Passive Operation and Haptic Perception Phenomena." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2007 (2007): _1A2—E06_1—_1A2—E06_4. http://dx.doi.org/10.1299/jsmermd.2007._1a2-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Wadnerkar, M. B., Ch Lam-Cassettari, A. Telling, and D. James. "E066 Enhancing maternal contingency using a video based rehabilitation with children with cochlear implants." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 73. http://dx.doi.org/10.1016/s0165-5876(11)70374-3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

YOSHINO, Kazuma, and Hiroyuki SHINODA. "1A1-E06 Contactless Touch Screen with Tactile Sensation(Haptic Interface (1))." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2013 (2013): _1A1—E06_1—_1A1—E06_4. http://dx.doi.org/10.1299/jsmermd.2013._1a1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

TAMAKI, Takeshi, Atsutoshi IKEDA, Yuichi KURITA, and Tsukasa OGASAWARA. "2P1-E06 Rheology-based posture control of a multi-link robot." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2009 (2009): _2P1—E06_1—_2P1—E06_2. http://dx.doi.org/10.1299/jsmermd.2009._2p1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

SHINAGAWA, Masaharu, Kenji KAWADA, Kazuo ISHII, Takeshi SAITO, and Kohji OKAMOTO. "1P1-E06 Construction of the headlight system with Gaze tracking function." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2015 (2015): _1P1—E06_1—_1P1—E06_2. http://dx.doi.org/10.1299/jsmermd.2015._1p1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Petrik, A., and G. Louzensky. "E06 Changes in composition of urinary stones in recurrent stone patients." European Urology Supplements 10, no. 7 (October 2011): 463. http://dx.doi.org/10.1016/s1569-9056(11)61154-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

NEUTEL, J. "E063 The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension." American Journal of Hypertension 11, no. 4 (April 1998): 111A. http://dx.doi.org/10.1016/s0895-7061(97)91125-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

PRETI, P. "E065 The cronology of development of the losartan antihypertensive efficacy: A 24-h ABPM study." American Journal of Hypertension 11, no. 4 (April 1998): 112A. http://dx.doi.org/10.1016/s0895-7061(97)91127-4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Bosco, E., P. Mancini, L. D'Agosta, G. Traisci, A. Musacchio, and R. Filipo. "E063 Formal use of visual gestural channel in paediatric cochlear implant users: Whys and wherefores." International Journal of Pediatric Otorhinolaryngology 75 (May 2011): 72. http://dx.doi.org/10.1016/s0165-5876(11)70371-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Masuzawa, Hiroaki, and Jun Miura. "2A1-E06 Environment Information Summarization by a Mobile Robot for Indoor Environments." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2008 (2008): _2A1—E06_1—_2A1—E06_4. http://dx.doi.org/10.1299/jsmermd.2008._2a1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Clark, Elizabeth. "E06-B Care for the Older Patient with Advanced Chronic Kidney Disease." Journal of Pain and Symptom Management 52, no. 6 (December 2016): e41. http://dx.doi.org/10.1016/j.jpainsymman.2016.10.112.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

SHIMIZU, Toshiyuki, and Naoyuki KUBOTA. "1P1-E06 Behavior Learning For Imitation Learning Based On SSGA And MNN." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2006 (2006): _1P1—E06_1—_1P1—E06_4. http://dx.doi.org/10.1299/jsmermd.2006._1p1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

SAKABA, Shunsuke, Yasuo HAYASHIBARA, and Kazuo TANIE. "2P1-E06 Autonomous Mobile Robot System which obtains Environmental Data from RFID." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2006 (2006): _2P1—E06_1—_2P1—E06_4. http://dx.doi.org/10.1299/jsmermd.2006._2p1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

NAKAMOTO, Hiroyuki, Satoru TAKENAWA, Kazuyuki ICHIMORI, Ryo NAKAE, Kenjiro KANDA, Futoshi KOBAYASHI, Fumio KOJIMA, et al. "2A1-E06 Shape Recognition Accuracy in Rotation Manipulation by Universal Robot Hand." Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec) 2007 (2007): _2A1—E06_1—_2A1—E06_2. http://dx.doi.org/10.1299/jsmermd.2007._2a1-e06_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!